Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents

Journal of Hepatology

Volumn 52, Issue 6, 2010, Pages 827-831

  Sokal, Etienne M ^a   Bourgois, Annick ^a   Stéphenne, Xavier ^a   Silveira, Themis ^b   Porta, Gilda ^c   Gardovska, Dace ^d   Fischler, Björn ^e   Kelly, Deirdre ^f  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d RIGA STRADINS UNIVERSITY   (Latvia)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Children; Hepatitis C; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; PEGINTERFERON ALPHA2A; RIBAVIRIN; THYROID HORMONE; THYROTROPIN; VIRUS RNA;

ABDOMINAL PAIN; ABNORMAL LABORATORY RESULT; ACUTE HEPATITIS; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ANEMIA; ANOREXIA; ARTHRALGIA; ARTICLE; ASTHENIA; BACTERIAL INFECTION; BLEEDING; BODY HEIGHT; CHILD; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DEPRESSION; DERMATITIS; DIARRHEA; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; DYSURIA; ENURESIS; FATIGUE; FEMALE; FLU LIKE SYNDROME; GENOTYPE; HEART PALPITATION; HEMOGLOBIN BLOOD LEVEL; HEPATITIS C; HUMAN; INJECTION SITE ERYTHEMA; INJECTION SITE INFECTION; INJECTION SITE PAIN; INSOMNIA; IRRITABILITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOOD; MULTICENTER STUDY; MYALGIA; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; PULMONARY HYPERTENSION; SIDE EFFECT; SORE THROAT; SUICIDAL IDEATION; SUICIDE ATTEMPT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THYROTOXICOSIS; VIRUS INFECTION; VOMITING; WEIGHT REDUCTION;

ADOLESCENT; ANTIVIRAL AGENTS; CHILD; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; PATIENT DROPOUTS; POLYETHYLENE GLYCOLS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RIBAVIRIN; RNA, VIRAL; TREATMENT OUTCOME;

EID: 77952419827     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.01.028     Document Type: Article

References (26)

1. Iorio R., Giannattasio A., Sepe A., Terracciano L.M., Vecchione R., and Vegnente A. Chronic hepatitis C in childhood: an 18-year experience. Clin Infect Dis 41 (2005) 1431-1437
2. Rumbo C., Fawaz L.R., Emre S.H., et al. Hepatitis C in children: quaternary referral center perspective. J Pediatr Gastroenterol Nutr 43 (2006) 209-216
3. Bortolotti F., Verucchi G., Cammà C., Cabibbo G., Zancan L., Indolfi G., et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134 (2008) 1900-1907
4. Guido M., Bortolotti F., Leandro G., Jara P., Hierro L., Larrauri J., et al. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?. Am J Gastroenterol 98 (2003) 660-663
5. Goodman Z.D., Makhlouf H.R., Liu L., Balistreri W., Gonzalez-Peralta R.P., Haber B., et al. Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial. Hepatology 47 (2008) 836-843
6. Rodrigue J.R., Balistreri W., Haber B., Jonas M.M., Mohan P., Molleston J.P., et al. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr 48 (2009) 341-347
7. Iorio R., Pensati P., Botta S., et al. Side effects of alfa-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis. Pediatr Infect Dis J 16 (1997) 984-990
8. Nydegger A., Srivastava A., Wake M., et al. Health-related quality of life in children with hepatitis C acquired in the first year of life. Hepatology 23 (2008) 226-230
9. Bortolotti F., Resti M., Giacchino R., Crivellaro C., Zancan L., Azzari C., Gussetti N., et al. Changing epidemiologic pattern of chronic hepatitis C virus infection in Italian children. J Pediatr 133 (1998) 378-381
10. Alter M.J. Epidemiology of hepatitis C. Hepatology 26 (1997) 625-665
11. Committee on Infectious Diseases, American Academy of Pediatrics. Hepatitis C virus infection. Pediatrics 101 (1998) 4881-4887
12. Minola E., Prati D., Suter F., et al. Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99 (2002) 4591
13. Casiraghi M.A., Paschale M.D., Romano L., et al. Long-term outcome (35 years) of hepatitis C after acquisition of infection through minitransfusions of blood given at birth. Hepatology 39 (2004) 90-96
14. Jara P., Resti M., Hierro L., Giacchino R., Barbera C., Zancan L., et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 36 (2003) 275-280
15. Jhaveri R., Grant W., Kauf T.L., and McHutchinson J. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 148 (2006) 353-358
16. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Gonçales Jr. F.L., et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 347 (2002) 975-982
17. Poynard T., Leroy V., Cohard M., Thevenot T., Mathurin P., Opolon P., et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24 (1996) 778-789
18. Carithers Jr. R.L., and Emerson S.S. Therapy of hepatitis C: meta-analysis of interferon alfa-2b trials. Hepatology 26 (1997) 83S-88S
19. Jacobson K.R., Murray K., Zellos A., and Schwarz K.B. An analysis of published trials of interferon monotherapy in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 34 (2002) 52-58
20. Wirth S., Lang T., Gehering S., and Gerner P. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36 (2002) 1280-1284
21. Reddy K.R., Wright T.L., Pockros P.J., et al. Efficacy and safety of pegylated (40-kd) interferon alpha-2a compared with interferon alpha-2a in noncirrhotic patients with chronic hepatitis C. Hepatology 33 (2001) 433-438
22. Lindsay K.L., Trepo C., Heintges T., et al. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 34 (2001) 395-403
23. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
24. Wirth S., Pieper-Boustani H., Lang T., Ballauff A., Kullmer U., Gerner P., et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 (2005) 1013-1018
25. Schwarz K.B., Mohan P., Narkewicz M.R., Molleston J.P., Nash S.R., Hu S., et al. Safety, efficacy and pharmacokinetics of peginterferon α2a (40 Kd) in children with chronic hepatitis C. J Pediatr Gastroenterol Nutr 43 (2006) 499-505
26. González-Peralta R.P., Kelly D.A., Haber B., Molleston J., Murray K.F., Jonas M.M., et al., International Pediatric Hepatitis C Therapy Group. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 42 (2005) 1010-1018